Voltage-dependent T-type calcium channel subunit (e.g., CaV3.1 subunit) (CaV3.x (where "x" designates the gene, e.g., CaV3.1, CaV3.2, CaV3.3))

Voltage-dependent T-type calcium channel subunits, primarily encoded by the genes CACNA1G (CaV3.1), CACNA1H (CaV3.2), and CACNA1I (CaV3.3), form low voltage-activated ion channels that mediate transient calcium influx in response to small depolarizations of the cell membrane[1][5][8]. These channels are distinguished by their fast inactivation kinetics and activation at more negative voltages than other calcium channels. T-type channels are essential regulators of pacemaking activity in the heart and neuronal firing patterns, particularly in thalamic and other rhythmic neurons. Dysregulation or abnormal expression of T-type calcium channels has been implicated in epilepsy, movement disorders (such as essential tremor and Parkinson’s disease), neuropathic pain, certain cancers, and other conditions. Several anti-epileptic drugs and novel small molecule blockers target these channels to reduce pathological neural excitability. Safety challenges include the risk of disrupting physiological rhythms in the heart and brain due to the channels’ key roles in normal cellular excitability[2][4][5][6][8].

Other names

T-type calcium channelLow voltage-activated calcium channelCaV3 channelT-type Ca2+ channelCACNA1G (CaV3.1)CACNA1H (CaV3.2)CACNA1I (CaV3.3)

Inhibition of T-type calcium channel reduces abnormal burst firing in neurons Suppression of low threshold calcium currents to prevent neuronal hyperexcitability and seizures Normalization of pacemaking and burst firing in specific brain circuits